{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:33:31Z","timestamp":1789598011669,"version":"build-2803163510"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Health Research Board","award":["HRA_POR\/2012\/56"],"award-info":[{"award-number":["HRA_POR\/2012\/56"]}]},{"name":"Health Research Board","award":["HRA_POR\/2010\/123"],"award-info":[{"award-number":["HRA_POR\/2010\/123"]}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["14\/ADV\/RC2721"],"award-info":[{"award-number":["14\/ADV\/RC2721"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["13\/SIRG\/2014"],"award-info":[{"award-number":["13\/SIRG\/2014"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Irish Centre for Fetal and Neonatal Translational Research","award":["12\/RC\/2272"],"award-info":[{"award-number":["12\/RC\/2272"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neuropharm.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T05:01:52Z","timestamp":1484024512000},"page":"351-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice"],"prefix":"10.1016","volume":"116","author":[{"given":"Natalia","family":"Rodriguez-Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Jimenez-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Reschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-8682","authenticated-orcid":false,"given":"Ron\u00e1n M.","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine B.","family":"Boylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Henshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.01.005_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","article-title":"Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons","volume":"29","author":"Anderson","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib3","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.22-14-05938.2002","article-title":"Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase","volume":"22","author":"Armstrong","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0166-2236(02)02241-5","article-title":"Stressed-out, or in (utero)","volume":"25","author":"Avishai-Eliner","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","article-title":"Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial","volume":"15","author":"Azzopardi","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrn920","article-title":"Excitatory actions of gaba during development: the nature of the nurture","volume":"3","author":"Ben-Ari","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib7","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/bph.12314","article-title":"Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567","volume":"170","author":"Bhattacharya","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib8","doi-asserted-by":"crossref","first-page":"15089","DOI":"10.1073\/pnas.222550499","article-title":"Antiepileptic drugs and apoptotic neurodegeneration in the developing brain","volume":"99","author":"Bittigau","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrd2605","article-title":"Purinergic signalling and disorders of the central nervous system","volume":"7","author":"Burnstock","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neuropharm.2014.01.045","article-title":"The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis","volume":"81","author":"Carmo","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib11","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1523\/JNEUROSCI.22-08-03061.2002","article-title":"ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels","volume":"22","author":"Chakfe","year":"2002","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib12","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/j.1460-9568.2012.08140.x","article-title":"Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette","volume":"35","author":"Chapman","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neuroscience.2005.03.032","article-title":"Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures","volume":"133","author":"Cheung","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/WNR.0b013e32833d9142","article-title":"P2X7 receptors enhance glutamate release in hippocampal hilar neurons","volume":"21","author":"Cho","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib15","doi-asserted-by":"crossref","first-page":"e57148","DOI":"10.1371\/journal.pone.0057148","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib16","first-page":"254","article-title":"A\u00a0new model of stroke and ischemic seizures in the immature mouse. Pediatr","volume":"31","author":"Comi","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib17","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.neurobiolaging.2011.09.040","article-title":"In\u00a0vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases","volume":"33","author":"Diaz-Hernandez","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib18","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1096\/fj.08-122275","article-title":"Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration","volume":"23","author":"Diaz-Hernandez","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40265-016-0554-7","article-title":"Pharmacotherapy for neonatal seizures: current knowledge and future perspectives","volume":"76","author":"Donovan","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib20","doi-asserted-by":"crossref","first-page":"13438","DOI":"10.1073\/pnas.96.23.13438","article-title":"Developmental regulation of spine motility in the mammalian central nervous system","volume":"96","author":"Dunaevsky","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/1531-8249(200010)48:4<632::AID-ANA10>3.0.CO;2-3","article-title":"Seizures accelerate anoxia-induced neuronal death in the neonatal rat hippocampus","volume":"48","author":"Dzhala","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nm1301","article-title":"NKCC1 transporter facilitates seizures in the developing brain","volume":"11","author":"Dzhala","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib23","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1056\/NEJMra1205750","article-title":"Purinergic signaling during inflammation","volume":"367","author":"Eltzschig","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuropharm.2015.11.001","article-title":"ATPergic signalling during seizures and epilepsy","volume":"104","author":"Engel","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib25","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib26","doi-asserted-by":"crossref","first-page":"e0156468","DOI":"10.1371\/journal.pone.0156468","article-title":"Critical evaluation of P2X7 receptor antagonists in selected seizure models","volume":"11","author":"Fischer","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib27","doi-asserted-by":"crossref","first-page":"44628","DOI":"10.1074\/jbc.M112.390971","article-title":"The specificity protein factor Sp1 mediates transcriptional regulation of P2X7 receptors in the nervous system","volume":"287","author":"Garcia-Huerta","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jpeds.2009.03.040","article-title":"Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury","volume":"155","author":"Glass","year":"2009","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11302-011-9272-5","article-title":"P2X receptor antagonists for pain management: examination of binding and physicochemical properties","volume":"8","author":"Gum","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0022-3476(98)70458-5","article-title":"High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up","volume":"132","author":"Hall","year":"1998","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib31","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1474-4422(04)00881-6","article-title":"Susceptibility of immature and adult brains to seizure effects","volume":"3","author":"Haut","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuroscience.2007.07.015","article-title":"P2 receptor expression in the dopaminergic system of the rat brain during development","volume":"149","author":"Heine","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eplepsyres.2009.09.019","article-title":"Antiepileptic drugs and brain development","volume":"88","author":"Ikonomidou","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF02229075","article-title":"An animal model of hypoxia-induced perinatal seizures","volume":"16","author":"Jensen","year":"1995","journal-title":"Ital. J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib35","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.clp.2009.08.001","article-title":"Neonatal Seizures: an update on mechanisms and management","volume":"36","author":"Jensen","year":"2009","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib36","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1038\/srep17486","article-title":"microRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus","volume":"5","author":"Jimenez-Mateos","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib37","doi-asserted-by":"crossref","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib38","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/epi.12257","article-title":"Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079","volume":"54","author":"Jimenez-Pacheco","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib39","doi-asserted-by":"crossref","first-page":"C1100","DOI":"10.1152\/ajpcell.00494.2003","article-title":"Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release","volume":"286","author":"Kahlenberg","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib40","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.tins.2006.05.007","article-title":"Early patterns of electrical activity in the developing cerebral cortex of humans and rodents","volume":"29","author":"Khazipov","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib42","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1172\/JCI44818","article-title":"The P2X7 receptor\u2013pannexin-1 complex decreases muscarinic acetylcholine receptor\u2013mediated seizure susceptibility in mice","volume":"121","author":"Kim","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib43","doi-asserted-by":"crossref","first-page":"e41229","DOI":"10.1371\/journal.pone.0041229","article-title":"Activation of P2X7 promotes cerebral edema and neurological injury after traumatic brain injury in mice","volume":"7","author":"Kimbler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/glia.20712","article-title":"Morphogenesis and regulation of Bergmann glial processes during Purkinje cell dendritic spine ensheathment and synaptogenesis","volume":"56","author":"Lippman","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib45","doi-asserted-by":"crossref","first-page":"F267","DOI":"10.1136\/archdischild-2011-300716","article-title":"Cooling and seizure burden in term neonates: an observational study","volume":"97","author":"Low","year":"2012","journal-title":"Arch. Dis. Child. Fetal Neonatal"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000443782","article-title":"Short-term effects of phenobarbitone on electrographic seizures in neonates","volume":"110","author":"Low","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib47","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00702-010-0400-0","article-title":"On the role of P2X7 receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X7 receptor antagonist A-438079","volume":"117","author":"Marcellino","year":"2010","journal-title":"J.\u00a0Neural Trans."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib48","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/cns.12272","article-title":"P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage","volume":"20","author":"Mesuret","year":"2014","journal-title":"CNS Neurosci. Thera"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib49","first-page":"229","article-title":"Neonatal seizures: early-onset seizure syndromes and their consequences for development","volume":"6","author":"Mizrahi","year":"2000","journal-title":"Ment. Ret. Dev. Disab. Res. Rev."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib50","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib71","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1523\/JNEUROSCI.16-04-01337.1996","article-title":"Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death","volume":"16","author":"Morrison","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib51","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1124\/mol.112.083758","article-title":"P2X receptors as drug targets","volume":"83","author":"North","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199908123410704","article-title":"Phenobarbital compared with phenytoin for the treatment of neonatal seizures","volume":"341","author":"Painter","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib53","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/00001756-200410250-00017","article-title":"Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-\/- mice","volume":"15","author":"Papp","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib54","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib55","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.brainres.2006.03.040","article-title":"P2X 7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain","volume":"1089","author":"Rappold","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.nbd.2015.08.023","article-title":"Effects of hypoxia-induced neonatal seizures on acute hippocampal injury and later-life seizure susceptibility and anxiety-related behavior in mice","volume":"83","author":"Rodriguez-Alvarez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib57","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1528-1167.2011.03241.x","article-title":"What is the value of hypothermia in acute neurologic diseases and status epilepticus","volume":"52","author":"Rossetti","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2014.06.008","article-title":"Sublime microglia: expanding roles for the guardians of the CNS","volume":"158","author":"Salter","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib59","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.4049\/jimmunol.164.9.4893","article-title":"Kinetics and mechanism of ATP-dependent IL-1\u03b2 release from microglial cells","volume":"164","author":"Sanz","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/NEN.0000000000000056","article-title":"Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia","volume":"73","author":"Schiering","year":"2014","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.21167","article-title":"Neonatal seizures","volume":"62","author":"Silverstein","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1074\/jbc.M006781200","article-title":"Altered cytokine production in mice lacking P2X(7) receptors","volume":"276","author":"Solle","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib63","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.tips.2014.08.002","article-title":"P2X7 receptor: an emerging target in central nervous system diseases","volume":"35","author":"Sperlagh","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib64","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperl\u00e1gh","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib65","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/pr.2012.151","article-title":"Antiepileptic effects of levetiracetam in a rodent neonatal seizure model","volume":"73","author":"Talos","year":"2013","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.siny.2013.05.008","article-title":"Epidemiology and aetiology of neonatal seizures. Semin","volume":"18","author":"Vasudevan","year":"2013","journal-title":"Fetal Neonatal. Med"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib67","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1523\/JNEUROSCI.23-25-08692.2003","article-title":"Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases","volume":"23","author":"Viviani","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib68","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1528-1167.2009.02339.x","article-title":"EEG spike activity precedes epilepsy after kainate-induced status epilepticus","volume":"51","author":"White","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2017.01.005_bib69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.devbrainres.2005.02.015","article-title":"Changes in expression of P2X purinoceptors in rat cerebellum during postnatal development","volume":"156","author":"Xiang","year":"2005","journal-title":"Brain Res. Dev. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.01.005_bib70","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1159\/000069049","article-title":"Prolonged neonatal seizures exacerbate hypoxic-ischemic brain damage: correlation with cerebral energy metabolism and excitatory amino acid release","volume":"24","author":"Yager","year":"2002","journal-title":"Dev. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:19:26Z","timestamp":1656069566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":71,"alternative-id":["S0028390817300059"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of P2X7 receptor antagonists on hypoxia-induced neonatal seizures in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}